纵横研报
Ticker Detail

600422.SHG

¥8.84-0.79% 昆药集团 Drug Manufacturers - Specialty & Generic
00Reports China 医疗健康
KPC Pharmaceuticals Inc
医疗健康 · 专科与仿制药

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections, and other products, as well as engages in the wholesale and retail of medicines and equipment. The company offers products in the field of cardiovascular and cerebrovascular, orthopedics series, antimalarial, gynecology, digestive system, and others treatments. It offers its products under Luotai, Tianxuanqing, Artemedine, Artem, and Arco brands. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals,Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.

MARKET 市值 6.27B CNY PE 55.2x Fwd 25.8x 52W ¥7.45 – ¥15.08 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY -48.0% ROE 2.4% 营业利润率 -20.5% 净利润率 2.0%
ANALYST 股息率 2.21%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制